Fanelli R D, Gersin K S, Mainella M T
Department of Surgery, Berkshire Medical Center, University of Massachusetts Medical School, c/o Surgical Specialists of Western New England, PC, 510 North Street, Suite 202, Pittsfield, MA 01201, USA.
Surg Endosc. 2002 Mar;16(3):487-91. doi: 10.1007/s00464-001-8176-9. Epub 2001 Nov 16.
Occult common bile duct stones (CBDS) discovered during laparoscopic cholecystectomy with intraoperative cholangiography are most often managed by postoperative endoscopic retrograde cholangiopancreatography (ERCP). Expert endoscopists at high-volume centers achieve common bile duct cannulation in nearly all patients undergoing ERCP, but cannulation rates of less than 80% have been observed in low-volume centers. As many as 20% of patients with CBDS referred for postoperative ERCP in low-volume centers may require repeated attempts at ERCP, referral to a high-volume center, percutaneous transhepatic techniques, or reoperation for clearance of CBDS when postoperative ERCP fails.
Laparoscopic cholecystectomy with intraoperative cholangiography performed in 511 consecutive patients over 80 months at a community hospital showed occult CBDS in 66 patients (12.9%). Laparoscopic endobiliary stent placement was successful in 65 patients (98.5%). As part of an earlier study, 16 patients underwent laparoscopic common bile duct exploration with clearance of CBDS before stent placement. Laparoscopic endobiliary stent placement failed in one patient for whom CBDS were cleared with intraoperative ERCP.
Initial postoperative ERCP was successful in clearing CBDS in all 65 patients (100%) with laparoscopically placed stents. During the same period, 611 patients underwent ERCP for various indications including CBDS (43%). Selective cannulation was achieved in 78% of all patients during initial ERCP.
Laparoscopic endobiliary stent placement is an effective adjunct to the management of occult CBDS. Laparoscopic endobiliary stenting ensures selective cannulation during postoperative ERCP and eliminates the need for repeated attempts at ERCP, referral to specialty centers, use of transhepatic techniques, or reoperation for retained CBDS. Laparoscopic endobiliary stent placement for treatment of occult CBDS significantly improves the success of postoperative ERCP in low-volume centers and eliminates the morbidity and expense of repeated procedures.
在腹腔镜胆囊切除术期间通过术中胆管造影发现的隐匿性胆总管结石(CBDS),大多通过术后内镜逆行胰胆管造影(ERCP)进行处理。大型中心的专业内镜医师在几乎所有接受ERCP的患者中都能成功进行胆总管插管,但在小型中心观察到的插管率低于80%。在小型中心,多达20%接受术后ERCP的CBDS患者在术后ERCP失败时可能需要多次尝试ERCP、转诊至大型中心、采用经皮肝穿刺技术或再次手术以清除CBDS。
在一家社区医院对连续511例患者进行了为期80个月的腹腔镜胆囊切除术及术中胆管造影,其中66例患者(12.9%)发现隐匿性CBDS。65例患者(98.5%)腹腔镜胆管内支架置入成功。作为一项早期研究的一部分,16例患者在支架置入前接受了腹腔镜胆总管探查并清除了CBDS。1例患者腹腔镜胆管内支架置入失败,但通过术中ERCP清除了CBDS。
所有65例通过腹腔镜置入支架的患者术后首次ERCP均成功清除了CBDS(100%)。同期,611例患者因包括CBDS(43%)在内的各种适应证接受了ERCP。在首次ERCP期间,所有患者中有78%实现了选择性插管。
腹腔镜胆管内支架置入是隐匿性CBDS处理的一种有效辅助手段。腹腔镜胆管内支架置入可确保术后ERCP期间的选择性插管,无需对ERCP进行多次尝试、转诊至专科中心、使用经肝技术或因残留CBDS而再次手术。腹腔镜胆管内支架置入治疗隐匿性CBDS显著提高了小型中心术后ERCP的成功率,并消除了重复操作的发病率和费用。